Abstract:OBJECTIVES:With the decreased protective effect of Bacille Calmette-Guérin (BCG) vaccine, widespread drug-resistant strains of tuberculosis as well as the lack of effective vaccines, global morbidity and mortality of tuberculosis remains high. The purpose of this study is to evaluate the potential of Mycobacterium tuberculosis antigen Rv2654 as a candidate vaccine against tuberculosis, and to verify the characteristics of cellular and humoral immune responses in mice induced by this protein.METHODS:Isopropyl-beta-D-thiogalactoside (IPTG) was added to induce the expression of Rv2654 recombinant protein in the logarithmic growth stage of bacteria. The recombinant protein was purified by affinity chromatography and identified by Western blotting. The immunoreactivity of Rv2654 recombinant protein with human sera was detected by ELISA. After immunization with Rv2654 recombinant protein, the levels of Th1/Th2 cytokines in peripheral blood of mice was measured using cytokine magnetic bead arrays, and the T and B lymphocyte subsets in spleen of mice was analyzed by flow cytometry.RESULTS:The recombinant protein Rv2654 was successfully induced and expressed. The ELISA data showed that the recombinant protein Rv2654 was responsive to the serum of BCG-inoculated patients or active pulmonary tuberculosis patients. In immunized mice with recombinant protein Rv2654, the expression of IFN-γ, TNF-α, IL-2, IL-4, IL-6, IL-10 and other cytokines in peripheral blood was elevated (all P<0.05). Flow cytometry analysis showed that the recombinant protein significantly stimulated the differentiation of CD4+T cells and CD8+T cells into effector T cells, and this effect was more obvious when combined with BCG. The recombinant protein Rv2654 also stimulated the activation and proliferation of B cells and their differentiation into memory cells. However, less plasma cells were produced.CONCLUSIONS:Rv2654 protein could induce the cell immune responses and it has good binding ability with serum of BCG-inoculated patients and active pulmonary tuberculosis patients, suggesting that it may serve as a good candidate antigen for tuberculosis immunological prophylaxis and diagnostic vaccines.

Recombinant protein Rv2346c inhibits the immunological response of macrophage against Mycobacterium tuberculosis

Expression and Purification of Rv2654 Recombinant Protein from Mycobacterium Tuberculosis and Its Characteristics of Immune Response.

Mycobacterium Tuberculosis Rv0426c Promotes Recombinant Mycobacteria Intracellular Survival Via Manipulating Host Inflammatory Cytokines and Suppressing Cell Apoptosis.

Mycobacterium Tuberculosis Rv0309 Dampens the Inflammatory Response and Enhances Mycobacterial Survival

Secreted Rv1768 From RD14 of Mycobacterium tuberculosis Activates Macrophages and Induces a Strong IFN-γ-Releasing of CD4 + T Cells.

Effect of Recombinant Mce4A Protein of Mycobacterium Bovis on Expression of TNF-α, Inos, IL-6, and IL-12 in Bovine Alveolar Macrophages

Mycobacterium Tuberculosis Rv3402c Enhances Mycobacterial Survival Within Macrophages and Modulates the Host Pro-Inflammatory Cytokines Production Via NF-kappa B/ERK/p38 Signaling.

Mycobacterium tuberculosis Rv3435c regulates inflammatory cytokines and promotes the intracellular survival of recombinant Mycobacteria

Rv2820c of Beijing/W Strains Enhances Mycobacterium Tuberculosis Survival in Human Macrophages

A Potential Target Gene for the Host-Directed Therapy of Mycobacterial Infection in Murine Macrophages.

Immunogenicity Analysis of a Recombinant BCG Vaccine Strain Overexpressing Rv3478 Protein

A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response

Recombinant Rv1654 protein of Mycobacterium tuberculosis induces mitochondria‐mediated apoptosis in macrophage

Recombinant Mycobacterium Bovis Bcg Expressing Chimaeric Protein of Ag85b and Esat-6 Enhances Immunostimulatory Activity of Human Macrophages

Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection

Mycobacterial Rv1804c Binds to the PEST Domain of IκBα and Activates Macrophage-Mediated Proinflammatory Responses

Expression of Rv2031c-Rv2626c Fusion Protein in Mycobacteriumï¿½smegmatis Enhances Bacillary Survival and Modulates Innate Immunity in Macrophages

Immune Response Induced by Mycobacterium Tuberculosis Rv2450 Protein in Mice

Recombinant Bacille Calmette-Guérin coexpressing Ag85B-IFN-γ enhances the cell-mediated immunity in C57BL/6 mice.

Mycobacterium Tuberculosis Rv0580c Impedes the Intracellular Survival of Recombinant Mycobacteria, Manipulates the Cytokines, and Induces ER Stress and Apoptosis in Host Macrophages Via NF-κB and P38/jnk Signaling

Mycobacterium tuberculosis protein Rv2652c enhances intracellular survival by inhibiting host immune responses